NCT04334577View on ClinicalTrials.gov

Study on Efficacy of Attenuated Zoster Vaccine, Live

PHASE3CompletedINTERVENTIONAL
Enrollment

25,000

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

July 18, 2021

Study Completion Date

July 18, 2021

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

live attenuated zoster vaccine

subcutaneous injection

BIOLOGICAL

placebo

subcutaneous injection

Trial Locations (2)

210009

Jiangsu Province Center for Disease Control and Prevention, Nanjing

310051

Zhejiang Provincial Center for Disease Control and Prevention, Hanzhou

Sponsors
All Listed Sponsors
lead

Changchun BCHT Biotechnology Co.

INDUSTRY

NCT04334577 - Study on Efficacy of Attenuated Zoster Vaccine, Live | Biotech Hunter | Biotech Hunter